Skip to main content

and
  1. Article

    Open Access

    Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study

    It has been reported that treatment with uracil-tegafur (UFT) has shown significantly better survival and relapse-free survival (RFS) than surgery alone. Therefore, we compared UFT with a combination therapy o...

    Y Park, K Okamura, S Mitsuyama, T Saito, J Koh, S Kyono in British Journal of Cancer (2009)

  2. Article

    Open Access

    Erratum: Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study

    Correction to: British Journal of Cancer (2009) 101, 598–604. doi:10.1038/sj.bjc.6605218 www.bjcancer.com Upon publication of this paper in Volume 101, the authors noticed an error in the data contained within...

    Y Park, K Okamura, S Mitsuyama, T Saito, J Koh, S Kyono in British Journal of Cancer (2009)